Abstract
Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.
| Original language | English |
|---|---|
| Pages (from-to) | 220-225 |
| Number of pages | 6 |
| Journal | Japanese Journal of Neurosurgery |
| Volume | 24 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Jan 1 2015 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Surgery
- Clinical Neurology
Cite this
An update on novel oral anticoagulants. / Ago, Tetsuro; Wakisaka, Yoshinobu; Kuroda, Junya.
In: Japanese Journal of Neurosurgery, Vol. 24, No. 4, 01.01.2015, p. 220-225.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An update on novel oral anticoagulants
AU - Ago, Tetsuro
AU - Wakisaka, Yoshinobu
AU - Kuroda, Junya
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.
AB - Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.
UR - http://www.scopus.com/inward/record.url?scp=84928593942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928593942&partnerID=8YFLogxK
U2 - 10.7887/jcns.24.220
DO - 10.7887/jcns.24.220
M3 - Article
AN - SCOPUS:84928593942
VL - 24
SP - 220
EP - 225
JO - Japanese Journal of Neurosurgery
JF - Japanese Journal of Neurosurgery
SN - 0917-950X
IS - 4
ER -